Host: Larry Kaskel, MD <br>

  Guest: Lawrence Rudel, PhD <br>


  
    Dr. Larry Rudel joins Dr. Larry Kaskel to discuss the enzyme ACAT2 and its confirmed relationship with LDL. Dr. Rudel's new study in mice raises a tantalizing possibility. By inhibiting ACAT2, will we one day be able to eat any kind of fat we want without raising our risk of heart disease?

Host: Larry Kaskel, MD Guest: Lawrence Rudel, PhD Dr. Larry Rudel joins Dr. Larry Kaskel to discuss the enzyme ACAT2 and its confirmed relationship with LDL. Dr. Rudel's new study in mice raises a tantalizing possibility. By inhibiting ACAT2, will we one day be able to eat any kind of fat we want without raising our risk of heart disease?

Inhibiting ACAT2 may help eliminate heart disease

Tune in to interviews with the top thought leaders in medicine exploring the clinical and professional issues that are foremost in the minds of the medical community. Join us at the Clinician's Roundtable for discussions on a vast range of topics that every medical professional should know about.

Share Inhibiting ACAT2 may help eliminate heart disease

Sign up to save your podcasts

Inhibiting ACAT2 may help eliminate heart disease

Inhibiting ACAT2 may help eliminate heart disease

More shows like Clinician's Roundtable

The Peter Attia Drive

Huberman Lab